Tatva Chintan schedules investor meeting with Pegasus Growth

Tatva Chintan Pharma Chem Limited notified stock exchanges on September 4, 2025, of a scheduled one-on-one physical meeting with investor Pegasus Growth LLP. The meeting is set to take place on September 10, 2025, to comply with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company affirmed that it would refer to publicly available information during the discussion. Furthermore, Tatva Chintan Pharma Chem Limited explicitly stated that no confidential or unpublished price sensitive information would be shared during the meeting.

The information regarding the meeting will be made available on the company's website. The announcement was signed by Ishwar Nayi, company secretary and compliance officer.